The Anxious Brain: The Bidirectional Link Between Migraine and Anxiety

You’re lying in bed on a Sunday night. No headache. No aura. But your chest is tight. Your mind is already scanning tomorrow’s calendar — the fluorescent lights, the deadlines, the chance that it will come. You haven’t had a migraine in five days, but your brain is already bracing for the next one.

This is what chronic migraine does. It doesn’t just steal the days when pain arrives. It colonizes the days in between.

If this feeling sounds familiar, you’re not imagining things. And you’re far from alone.

Migraine and anxiety are two of the most common neurological and psychiatric conditions on earth. But they don’t simply coexist. They feed each other in a loop so tight that treating one without addressing the other often means treating neither. The neuroscience behind this loop reveals something genuinely surprising — and practically useful — about how your brain works.

The Numbers That Stopped Me Cold

A meta-analysis of over 15,000 people with migraine and 77,000 controls found that people with migraine are three times more likely to experience anxiety — an odds ratio of 3.18.^[1] That’s not a subtle association. That’s a red flag in neon.

It goes deeper. Anxiety symptoms appear in up to 47% of people living with migraine.^[2] A population-based study of over 356,000 migraine patients found anxiety prevalence of 24.6%, compared to 14.1% in matched controls — a twofold increased risk.^[3]

But here’s the part that reframes everything: the relationship runs in both directions. Longitudinal research by Breslau and colleagues demonstrated that migraine increases the risk of developing anxiety, and anxiety increases the risk of developing migraine.^[4] Each condition predicts the future onset of the other. This isn’t correlation. This is a feedback loop hardwired into your neurobiology.

Same Wiring, Different Symptoms

Why would a headache disorder and a mood disorder be so tangled? Because they share the same neural infrastructure.

Serotonin — the molecule that does too much. During a migraine attack, serotonin levels drop.^[5] This depletion leaves blood vessels without their normal tone and fires up the trigeminal pain pathway. The same serotonin system that derails during migraine is the one regulating mood, sleep, and anxiety. Genetic variations in the enzyme that produces serotonin — tryptophan hydroxylase — have been linked to increased susceptibility to both conditions.^[5] One factory. Two assembly lines. Both malfunctioning.

CGRP — the migraine molecule that also drives fear. Calcitonin gene-related peptide has become the star of migraine research. When the trigeminal nerve fires during an attack, it floods surrounding blood vessels with CGRP, triggering inflammation and pain.^[6] But CGRP doesn’t stay in pain circuits. It concentrates heavily in the amygdala — the brain’s threat-detection center — and in the hippocampus, where memories and emotional regulation live.^[7]

Here’s the finding that changed how I understand my own brain: a 2024 study in Communications Biology showed that CGRP directly causes anxiety by depleting dopamine in the hippocampus.^[8] The mechanism is elegant and unsettling. CGRP activates an enzyme called MAOB that breaks down dopamine — the neurotransmitter your brain needs to stay calm and focused. The same molecule that gives you migraine pain literally rewires your emotional thermostat toward anxiety.

The amygdala connection. CGRP signaling between the parabrachial nucleus and the central nucleus of the amygdala drives fear and anxiety responses through sensitization of NMDA receptors — the same glutamate receptors involved in central sensitization during migraine.^[6] Think of it as your brain’s alarm system stuck on high sensitivity. Every signal gets amplified, whether it’s pain or worry.

The Body Remembers What the Mind Tries to Forget

Bessel van der Kolk writes in The Body Keeps the Score that trauma and chronic stress don’t just live in our thoughts — they become embedded in our bodies. The nervous system doesn’t forget. It adapts, often in ways that create new problems.

This insight is profoundly relevant to migraine. Each attack is a neurological event, yes. But it is also a somatic experience that your body records. The nausea, the light sensitivity, the helplessness of lying in a dark room — these aren’t abstract memories. They become encoded in your nervous system’s threat library. Over time, your brain doesn’t need an actual trigger. The anticipation of an attack becomes sufficient to activate the same stress pathways.

Van der Kolk’s work explains why chronic pain conditions so often travel with anxiety: the body stays in a state of defensive readiness long after the immediate threat has passed. Your muscles tense before you consciously feel afraid. Your breathing shallows. Your heart rate creeps up. The migraine hasn’t started, but your body is already responding as if it has.

This is the physiological basis of what researchers call allostatic load — the cumulative cost of chronic stress on a system designed for acute emergencies.^[13] Your hypothalamic-pituitary-adrenal (HPA) axis, the body’s central stress command, runs chronically hot. Ordinary stimuli start registering as threats. A flickering light. A strong smell. A tight deadline. Each one becomes a potential trigger — not because you’re fragile, but because your nervous system has been trained by years of repeated neurological assault.

The Invisible Suffering Between Attacks

There’s a concept in headache medicine that deserves far more attention: interictal burden — the suffering that happens when you don’t have a migraine.

Most research and treatment focuses on the attack itself. But growing evidence shows that the time between attacks can inflict equal damage. In a survey of people with migraine, 67% reported severe interictal burden.^[9] A 2026 Japanese study found something remarkable: interictal burden — not the headache itself — was the primary driver of work productivity loss.^[10]

What does interictal burden look like? Anticipatory anxiety. Fear of the next attack. Avoidance of anything that might provoke one. Difficulty making plans or commitments. Researchers have coined a term for this: cephalalgiaphobia — the fear of headache itself.^[11]

This creates a textbook fear-avoidance cycle. You fear the next attack, so you skip the dinner, cancel the trip, say no to the project. The avoidance shrinks your world. The smaller world increases stress and isolation. The stress lowers your migraine threshold. The attack comes sooner. The fear deepens.

Guy Winch describes this pattern in Emotional First Aid: chronic illness creates what he calls “psychological wounds” — not just the disease itself, but the secondary losses it inflicts. Loss of control. Loss of predictability. Loss of the identity you had before the condition took over. These wounds, left untreated, fester. The person who once traveled freely now declines invitations. The professional who thrived under pressure now catastrophizes about deadlines. The friend who was always available now isolates — not because of pain, but because of the fear of pain that hasn’t arrived yet.

I’ve lived inside this cycle for 30 years. There were stretches when I managed migraine and anxiety simultaneously without realizing they were the same problem wearing different masks.

Breaking the Loop: What Actually Works

Because migraine and anxiety share biological pathways, treating one often helps the other. But the approach matters.

CGRP-targeted treatments. The new generation of migraine-specific preventives — monoclonal antibodies like erenumab, galcanezumab, and fremanezumab — don’t just reduce migraine days. A 2024 review found that erenumab and galcanezumab were associated with significant improvements in concurrent anxiety and depression.^[14] In a real-world Greek registry, 43% of chronic migraine patients with psychiatric comorbidities saw their anxiety severity decrease or resolve entirely after fremanezumab treatment.^[15] The 2025 UNITE trial — the first randomized controlled trial specifically designed to study a CGRP antibody in patients with comorbid migraine and major depressive disorder — showed fremanezumab significantly reduced both migraine days and depressive symptoms.^[16]

The biological logic is straightforward. If CGRP drives both pain and anxiety through shared pathways, blocking CGRP should quiet both.

Cognitive behavioral therapy. A 2025 systematic review and meta-analysis of 50 randomized trials (over 6,000 adults) found that CBT, relaxation training, and mindfulness-based therapies each reduce migraine frequency.^[17] But CBT does something medications cannot: it directly targets the anticipatory anxiety and avoidance behaviors that drive interictal burden.

CBT for migraine works by identifying the thought patterns that amplify the fear cycle — catastrophizing about attacks, overestimating triggers, avoiding life out of proportion to actual risk.^[18] A three-armed RCT found that migraine-specific CBT led to a 30% or greater reduction in headache days for 44% of participants at 12-month follow-up.^[18] When combined with preventive medication, it addresses both the neurological and psychological architecture of the loop.

The dual approach. The emerging clinical consensus is clear: for people with comorbid migraine and anxiety, treating only one condition leaves the other to keep stoking the fire.^[19] Headache specialists are increasingly urged to screen routinely for anxiety, and mental health professionals need to understand that their anxious patients may have an untreated neurological component.^[2]

Rewriting the Story of Your Brain

Susan Cain, in Bittersweet, makes an observation that resonates deeply with anyone living at the intersection of chronic pain and chronic worry: the most profound growth often comes not from escaping suffering, but from integrating it. She writes about the power of acknowledging vulnerability — of allowing sadness and limitation to coexist with meaning and purpose.

For those of us with migraine, this isn’t abstract philosophy. It’s a daily practice. The question isn’t whether your brain will sometimes betray you with pain and anxiety. It will. The question is what you build around that reality.

Understanding the bidirectional link gives you something powerful: an explanation. Your anxiety isn’t a personal weakness. Your migraine isn’t “just a headache.” They are two expressions of a shared neurological vulnerability — and that vulnerability responds to treatment.

Ask your doctor about screening. If you have migraine, request anxiety screening with the GAD-7 — it takes two minutes. If you have anxiety, mention your headache patterns, even if they seem unrelated.^[2]

Track what happens between attacks. Don’t just log pain days. Note your worry levels, avoidance behaviors, difficulty planning. This data helps your clinician see the full picture — and it helps you see the pattern.

Consider combination treatment. The most effective approach for comorbid migraine and anxiety often pairs a migraine-specific preventive with behavioral therapy.^[19] Neither alone is enough when both conditions are active.

Break the avoidance cycle — gently. Accept one invitation you’d normally decline. Make one plan without a backup excuse. Each time you engage with life despite the fear of an attack, you weaken the neural pathway that says “danger.” Van der Kolk’s research shows that the body can be retrained — slowly, safely, through repeated exposure to the experiences it has learned to fear.